BMP4 inhibits proliferation and promotes myocyte differentiation of lung fibroblasts via Smad1 and JNK pathways

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 288, Issue 2 32-2, 2005, Pages

  Jeffery, Trina K ^a   Upton, Paul D ^a   Trembath, Richard C ^b   Morrell, Nicholas W ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

smooth muscle actin; Bone morphogenetic protein type II receptor; Cell cycle; Mitogen activated protein kinase; Pulmonary

Indexed keywords

ACTIVIN RECEPTOR 1; ACTIVIN RECEPTOR 2; ALPHA SMOOTH MUSCLE ACTIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CYCLIN D; CYCLIN DEPENDENT KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOSIN; OSTEOGENIC PROTEIN 1; PROTEIN P21; SMAD1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; LUNG BLOOD VESSEL; LUNG FIBROBLAST; MUSCLE CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ACTIVIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; DNA; DNA-BINDING PROTEINS; FIBROBLASTS; HUMANS; INTRACELLULAR MEMBRANES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIGANDS; LUNG; MYOCYTES, SMOOTH MUSCLE; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RECEPTORS, GROWTH FACTOR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SMAD PROTEINS; SMAD1 PROTEIN; TRANS-ACTIVATORS;

EID: 12144274863     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00242.2004     Document Type: Article

References (48)

1. Agrotis A, Samuel M, Prapas G, and Bobik A. Vascular smooth muscle cells express multiple type I receptors for TGF-β, activin, and bone morphogenetic proteins. Biochem Biophys Res Commun 219: 613-618, 1996.
2. Atkinson C, Stewart S, Upton PD, Machado R, Thomson JR, Trembath RC, and Morrell NW. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation 105: 1672-1678, 2002.
3. Bogatkevich GS, Tourkina E, Silver RM, and Ludwicka-Bradley A. Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway. J Biol Chem 276: 45184-45192, 2001.
4. Chambers RC, Leoni P, Kaminski N, Laurent GJ, and Heller RA. Global expression profiling of fibroblast responses to transforming growth factor-β1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol 162: 533-546, 2003.
5. Cool CD, Stewart JS, Werahera P, Miller GJ, Williams RL, Voelkel NF, and Tuder R. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Am J Pathol 155: 411-419, 1999.
6. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, Hodge SE, and Knowles JA. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 67: 737-744, 2000.
7. Dorai H, Vukicevic S, and Sampath TK. Bone morphogenetic protein-7 (OP-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro. J Cell Physiol 184: 37-45, 2000.
8. Engel ME, McDonnell MA, Law BK, and Moses HL. Interdependent SMAD and JNK signaling in transforming growth factor-β-mediated transcription. J Biol Chem 274: 37413-37420, 1999.
9. Fouty BW, Grimison B, Fagan KA, Le Cras TD, Harral JW, Hoedt-Miller M, Sclafani RA, and Rodman DM. p27Kip1 is important in modulating pulmonary artery smooth muscle cell proliferation. Am J Respir Cell Mol Biol 25: 652-658, 2001.
10. Frolik CA, Wakefield LM, Smith DM, and Sporn MB. Characterization of a membrane receptor for transforming growth factor-β in normal rat kidney fibroblasts. J Biol Chem 259: 10995-11000, 1984.
11. Gallea S, Lallemand F, Atfi A, Rawadi G, Ramez V, Spinella-Jaegle S, Kawai S, Faucheu C, Huet L, Baron R, and Roman-Roman S. Activation of mitogen-activated protein, kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28: 491-498, 2001.
12. Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, and Choudhury GG. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 277: 33361-33368, 2002.
13. 2-terminal kinase-dependent pathway. J Allergy Clin Immunol 107: 1001-1008, 2001.
14. 2-terminal kinase-dependent pathway. Am J Respir Crit Care Med 163: 152-157, 2001.
15. Hu B, Wu Z, and Phan SH. Smad3 mediates transforming growth factor-β-induced α-smooth muscle actin expression. Am J Respir Cell Mol Biol 29: 397-404, 2003.
16. Iwasaki S, Iguchi M, Watanabe K, Hoshino R, Tsujimoto M, and Kohno M. Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC12 cells by bone morphogenetic protein-2. J Biol Chem 274: 26503-26510, 1999.
17. Jeffery TK and Morrell NW. Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Prog Cardiovasc Dis 45: 173-202, 2002.
18. Jiao K, Zhou Y, and Hogan BL. Identification of mZnf8, a mouse Kruppel-like transcriptional repressor, as a novel nuclear interaction partner of Smad1. Mol Cell Biol 22: 7633-7644, 2002.
19. Jones R, Jacobson M, and Steudel W. α-Smooth muscle actin and microvascular precursor smooth muscle cells in pulmonary hypertension. Am J Respir Cell Mol Biol 20: 582-594, 1999.
20. Kawabata M, Imamura T, and Miyazano K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 9: 49-61, 1998.
21. Kimura N, Matsuo R, Shibuya H, Nakashima K, and Taga T. BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem 275: 17647-17652, 2000.
22. Lai CF and Cheng SL. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-β in normal human osteoblastic cells. J Biol Chem 277: 15514-15522, 2002.
23. 22a. Lane KB, Machado RD, Pauciulo MW, Thomson JR, Philips JA, Loyd JE, Nichols WC, and Trembath RC. Heterozygous germ-line mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 26: 81-84, 2000.
24. Lemonnier J, Ghayor C, Guicheux J, and Caverzasio J. Protein kinase C-independent activation of protein kinase D is involved in BMP-2-induced activation of stress mitogen-activated protein kinases JNK and p38 and osteoblastic cell differentiation. J Biol Chem 279: 259-264, 2004.
25. Leslie KO, Mitchell JJ, Woodcock-Mitchell JL, and Low RB. α-Smooth muscle actin expression in developing and adult human lung. Differentiation 44: 143-149, 1990.
26. Macias-Silva M, Hoodless PA, Tang SJ, Buchwald M, and Wrana JL. Specific activation of smad1 signaling pathways by the BMP7 type I receptor, ALK2. J Biol Chem 273: 25628-25636, 1998.
27. Monzen K, Hiroi Y, Kudoh S, Akazawa H, Oka T, Takimoto E, Hayashi D, Hosoda T, Kawabata M, Miyazono K, Ishii S, Yazaki Y, Nagai R, and Komuro I. Smads, TAK1, and their common target ATF-2 play a critical role in cardiomyocyte differentiation. J Cell Biol 153: 687-698, 2001.
28. Morrell NW, Yang X, Upton PD, Jourdan KB, Morgan N, Sheares KK, and Trembath RC. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-β1 and bone morphogenetic proteins. Circulation 104: 790-795, 2001.
29. Moustakas A and Kardassis D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci USA 95: 6733-6738, 1998.
30. Nakamura Y, Ozaki T, Koseki H, Nakagawara A, and Sakiyama S. Accumulation of p27 KIP1 is associated with BMP2-induced growth arrest and neuronal differentiation of human neuroblastoma-derived cell lines. Biochem Biophys Res Commun 307: 206-213, 2003.
31. Nakaoka T, Gonda K, Ogita T, Otawara-Hamamoto Y, Okabe F, Kira Y, Harii K, Miyazono K, Takuwa Y, and Fujita T. Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J Clin Invest 100: 2824-2832, 1997.
32. Nicolas FJ and Hill CS. Attenuation of the TGF-β-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-β-induced growth arrest. Oncogene 22: 3698-3711, 2003.
33. Ohga E, Matsuse T, Teramoto S, Katayama H, Nagase T, Fukuchi Y, and Ouchi Y. Effects of activin A on proliferation and differentiation of human lung fibroblasts. Biochem Biophys Res Commun 228: 391-396, 1996.
34. Pardali K, Kurisaki A, Moren A, ten Dijke P, Kardassis D, and Moustakas A. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-β. J Biol Chem 275: 29244-29256, 2000.
35. Pouliot F and Labrie C. Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells. J Endocrinol 172: 187-198, 2002.
36. Raval P, Hsu HH, Schneider DJ, Sarras MP Jr, Masuhara K, Bonewald LF, and Anderson HC. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells. J Dent Res 75: 1518-1523, 1996.
37. Roberts AB. The ever increasing complexity of TGF-β signaling. Cytokine Growth Factor Rev 13: 3-5, 2002.
38. Ronnov-Jessen L and Petersen OW. A function for filamentous α-smooth muscle actin: retardation of motility in fibroblasts. J Cell Biol 134: 67-80, 1996.
39. Rudarakanchana N, Flanagan JA, Chen H, Upton PD, Machado RD, Patel D, Trembath RC, and Morrell NW. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genet 11: 1517-1525, 2002.
40. Sano Y, Harada J, Tashiro S, Gotoh-Mandeville R, Maekawa T, and Ishii S. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling. J Biol Chem 274: 8949-8957, 1999.
41. Short M, Nemenoff RA, Zawada WM, Stenmark KR, and Das M. Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts. Am J Physiol Cell Physiol 286: C416-C425, 2004.
42. Smith P, Heath D, Yacoub M, Madden B, Caslin A, and Gosney J. The ultrastructure of plexogenic pulmonary arteriopathy. J Pathol 160: 111-121, 1990.
43. Stenmark KR and Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol 59: 89-144, 1997.
44. Strauss BH and Rabinovitch M. Adventitial fibroblasts: defining a role in vessel wall remodeling. Am J Respir Cell Mol Biol 22: 1-3, 2000.
45. Ten Dijke P, Yamashita H, Ichijo H, Franzen P, Laiho M, Miyazono K, and Heldin CH. Characterization of type I receptors for transforming growth factor-β and activin. Science 264: 101-104, 1994.
46. Wong GA, Tang V, El Sabeawy F, and Weiss RH. BMP-2 inhibits proliferation of human aortic smooth muscle cells via p21Cip1/Waf1. Am J Physiol Endocrinol Metab 284: E972-E979, 2003.
47. Yi E, Kim H, Ahn H, Strother J, Morris T, Masliah E, Hansen LA, Park K, and Friedman PJ. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. Am J Respir Crit Care Med 162: 1577-1586, 2000.
48. You L and Kruse FE. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway. Invest Ophthalmol Vis Sci 43: 72-81, 2002.